FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
Semaglutide and liraglutide are sold under the brand names Wegovy, Ozempic, Rybelsus and Saxenda and are manufactured by Novo Nordisk
Learn more about how to become an American Cancer Society partner today. Help us fight cancer, improve cancer research and save lives.
An official journal of the British Society for Haematology, theĀ British Journal of HaematologyĀ offers high visibility for clinical, basic and translational research.
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
Many older adults needing hospital care are getting stuck in emergency room limbo ā sometimes for over a day ā affecting those with multiple health…
Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences…
At one health system, doctors completed one-third of required training modules during off hours. Find out how to cut this physician burden.
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy did not appear to improve progression-free survival when compared to radiation therapy…
Video games used during play can benefit childrenās well-being, if designed with their needs in mind, a new study from the University of Sheffield, LEGO…